Is Velan Stock a Buy at 52-Week Highs?

Velan stock just surged by 30% in share price after stellar third-quarter earnings, but is the stock now still a buy?

| More on:
Confused person shrugging

Source: Getty Images

Velan (TSX:VLN) recently caught the attention of investors, surging in share price by 30% this week on stellar third-quarter results. This dramatic rise reflects market confidence in the company’s strategic direction and recent financial performance. Let’s dive deeper into its earnings, past performance, future outlook, and whether the stock deserves its current momentum or not.

Created with Highcharts 11.4.3Velan PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Into earnings

Velan reported sales of $73.4 million in the third quarter (Q3), an 18.1% year-over-year increase driven by strong shipments from its Italian operations for oil and gas markets and the petrochemical sector in China. The gross profit soared to $28.3 million, or 38.6% of sales, compared to $8.2 million (13.1% of sales) last year, reflecting efficiency gains, a favourable product mix, and reduced exposure to problematic contracts.

Adjusted net income from continuing operations reached $8.5 million or $0.39 per share, a stark improvement from a $7.0 million adjusted net loss of $0.32 per share in Q3 2024. This turnaround was primarily attributed to higher sales volumes and gross profit. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also jumped significantly to $14.3 million. Compared to negative $4.1 million last year, showcasing Velan’s enhanced operational efficiency.

However, the company recorded a net loss of $47.8 million, largely due to one-time restructuring costs of $74.5 million related to the divestiture of asbestos liabilities. Excluding these costs, the company’s adjusted financials demonstrate a much healthier position.

Growing strength

Velan stock’s recent announcement to divest its asbestos-related liabilities is a game-changer. By transferring its liabilities to a subsidiary and selling it to Global Risk Capital, Velan effectively removes significant legacy risks. This transaction, though expensive upfront at $143 million, clears its balance sheet of a major drag and indemnifies the company from future asbestos-related obligations.

Furthermore, Velan stock’s order backlog grew by 5.3% since the start of the fiscal year. Now reaching $298.7 million, with $249.1 million (83.4%) expected to be delivered within the next 12 months. This backlog, combined with recent nuclear energy initiatives, positions Velan stock to capitalize on global clean energy trends. Including opportunities in small modular reactors and life-extension projects for existing nuclear facilities.

Despite slightly lower bookings for the quarter to $59.1 million compared to $60.1 million last year, the nine-month total bookings of $230.5 million mark a significant 30% increase year over year. This reflects Velan stock’s growing relevance in markets like North America and Germany, though challenges remain in regions like Italy.

What to consider

Velan stock reinstated a quarterly dividend of $0.03 per share, reflecting management’s confidence in the company’s financial stability and future growth prospects. While the payout is modest, it signals a commitment to shareholder returns, with a potential for increases post-transaction closings. The company’s net cash position of $32.1 million and manageable long-term debt of $19.5 million suggest a stable financial foundation.

While Velan stock’s underlying business is improving, the stock is not without risks. The company’s restructuring costs have led to significant headline losses, which may deter risk-averse investors. The book-to-bill ratio of 0.81 for the quarter reflects a slight decline in order replenishment rates, though the nine-month ratio of 1.09 suggests strong overall demand. Investors should also monitor currency fluctuations, which have had minor but measurable impacts on the company’s financials.

Bottom line

Velan stock’s Q3 results and strategic initiatives paint a picture of a company in transition but on a promising path. The surge in gross profit, significant backlog, and targeted divestitures indicate a company strengthening its core business while addressing past liabilities. The reinstatement of a dividend adds further confidence in its trajectory.

However, Velan stock’s recent 30% surge may have already priced in much of this optimism. Investors looking for long-term growth, particularly in the clean energy sector, may find Velan stock appealing. For others, waiting for further clarity on transaction outcomes or a potential dip in share price could present a better entry point. So, Velan stock appears to be a calculated but potentially rewarding buy for investors comfortable with some short-term volatility — all in exchange for exposure to a turnaround story with long-term growth prospects.

Should you invest $1,000 in The Bank of Nova Scotia right now?

Before you buy stock in The Bank of Nova Scotia, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and The Bank of Nova Scotia wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Muscles Drawn On Black board
Dividend Stocks

Where Will Power Corporation Be in 5 Years?

Here's how Power Corporation of Canada (TSX:POW) stock could generate double-digit returns and outperform financial sector peers in five years...

Read more »

view of skyscapers from below
Dividend Stocks

Where I’d Invest $5,500 in the TSX Today

Seeking to invest $5,500 in the TSX? Here’s a look at two stellar picks that can provide decades of growth…

Read more »

shopper buys items in bulk
Dividend Stocks

The Smartest Consumer Defensive Stock to Buy With $2,700 Right Now

Here's why Loblaw (TSX:L) is among the best consumer defensive stocks investors can consider in this increasingly uncertain environment.

Read more »

Forklift in a warehouse
Dividend Stocks

How I’d Build a $250 Monthly Income Stream With $14,000

The trick to earning $250+/month is reinvesting dividends and adding to your portfolio over time.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

The Top Canadian Stocks to Buy Immediately With $4,000

Insurance stocks are some of the strongest options, because we all need to pay it! And these three look top…

Read more »

dividends grow over time
Dividend Stocks

This Incredible Monthly Payer Is Down 17% and Looks Irresistible

Are you looking for an alternative source for a monthly paycheck? This stock is an irresistible deal to lock in…

Read more »

top TSX stocks to buy
Dividend Stocks

This Monthly Income TSX Stock Paying 2.7% Looks Like a Bargain Today

Savaria is a TSX dividend stock that has crushed broader market returns over the past two decades. Is the Canadian…

Read more »

data analyze research
Dividend Stocks

This Canadian Blue-Chip Down 36% Is a Once-in-a-Decade Opportunity 

Rarely does an opportunity come to buy a blue-chip stock at a decade-low price. It helps you catch up on…

Read more »